These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP. Iwasa Y, Mizokami A, Miwa S, Koshida K, Namiki M. Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262 [Abstract] [Full Text] [Related]
4. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype. Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z. Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613 [Abstract] [Full Text] [Related]
7. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor. Zhang Y, Ma Y, Lu HP, Gao JH, Liang CS, Liu CZ, Zou JT, Wang HQ. Chin Med J (Engl); 2008 Nov 20; 121(22):2284-9. PubMed ID: 19080333 [Abstract] [Full Text] [Related]
8. Beta-2-microglobulin expression correlates with high-grade prostate cancer and specific defects in androgen signaling. Mink SR, Hodge A, Agus DB, Jain A, Gross ME. Prostate; 2010 Aug 20; 70(11):1201-10. PubMed ID: 20564426 [Abstract] [Full Text] [Related]
9. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. Pinzani P, Lind K, Malentacchi F, Nesi G, Salvianti F, Villari D, Kubista M, Pazzagli M, Orlando C. Hum Pathol; 2008 Oct 20; 39(10):1474-82. PubMed ID: 18619642 [Abstract] [Full Text] [Related]
10. Genistein affects androgen-responsive genes through both androgen- and estrogen-induced signaling pathways. Takahashi Y, Hursting SD, Perkins SN, Wang TC, Wang TT. Mol Carcinog; 2006 Jan 20; 45(1):18-25. PubMed ID: 16299812 [Abstract] [Full Text] [Related]
11. Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells. Ngan S, Stronach EA, Photiou A, Waxman J, Ali S, Buluwela L. Oncogene; 2009 May 14; 28(19):2051-63. PubMed ID: 19363526 [Abstract] [Full Text] [Related]
12. The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells. van den Bemd GJ, Jhamai M, Brinkmann AO, Chang GT. Biochem Biophys Res Commun; 2003 Dec 19; 312(3):578-84. PubMed ID: 14680804 [Abstract] [Full Text] [Related]
13. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Xu Y, Dalrymple SL, Becker RE, Denmeade SR, Isaacs JT. Clin Cancer Res; 2006 Jul 01; 12(13):4072-9. PubMed ID: 16818707 [Abstract] [Full Text] [Related]
18. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis. Downing S, Bumak C, Nixdorf S, Ow K, Russell P, Jackson P. Mol Carcinog; 2003 Nov 01; 38(3):130-40. PubMed ID: 14587098 [Abstract] [Full Text] [Related]
19. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2. Bauer JA, Thompson TA, Church DR, Ariazi EA, Wilding G. Prostate; 2003 May 15; 55(3):159-67. PubMed ID: 12692781 [Abstract] [Full Text] [Related]